The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells.

Br J Dermatol

Department of Medical and Surgical Specialities, First Dermatologic Clinic, University of Turin, Via Cherasco 23, 10126 Torino, Italy.

Published: January 2001

Background: The lack of specific markers for the phenotyping of circulating neoplastic T cells in Sézary syndrome (SS) patients makes it difficult both to ascertain the presence of clonal cells and to quantify the tumour burden in the peripheral blood. In previous reports we showed that the lack of CD26 (dipeptidyl-aminopeptidase IV) is a characteristic feature of circulating Sézary cells (SC).

Objectives: The purpose of this study was to ascertain, by means of high-resolution two-, three- or four-parameter flow cytometry, the relationship between CD26 expression on peripheral blood lymphocytes and peripheral blood involvement in cutaneous T-cell lymphoma patients and to assess its significance in SS diagnosis.

Methods: The patient population included 52 SS patients, 151 mycosis fungoides (MF) patients at different clinical stages (including 14 with blood involvement, B1-MF), 88 patients with erythrodermic inflammatory skin diseases (EISD) and 72 healthy donors (HD). CD26+ values were available in all cases, whereas CD4+ CD26- level measurement was performed in 23 SS, 141 MF, 71 EISD and 72 HD.

Results: CD4+ CD26- percentage values were higher than 30% in all but one B1-MF and higher than 40% in all SS cases, whereas HD, EISD and B0-MF patient values were always lower than 30%. A statistically significant difference was found in both CD26- and CD4+ CD26- percentage and absolute values between SS and HD, EISD and B0-MF patients. The CD26- and CD4+ CD26- percentage values (but not the absolute values) were significantly higher in B1-MF compared with HD, EISD and B0-MF patients (P < 0.001). Moreover, CD26- absolute values and CD4+ CD26- percentage and absolute values were significantly higher in SS than in B1-MF (P < 0.001). A statistically significant direct relationship was found between CD4+ CD26- percentage values and the percentage of circulating SC within the lymphoid population in SS and B1-MF (r = 0.77; P < 0.001). The lack of CD26 was confirmed on phenotypically clonal cells in patients with an expanded circulating TCRvbeta population or a T-cell antigen loss. Sorted CD4+ CD26- cells from both SS patients and HD showed the characteristic cerebriform nuclei of SC.

Conclusions: We feel that a CD4+ CD26- percentage value higher than 30% of peripheral blood lymphocytes could correctly identify the presence of peripheral blood involvement in SS and MF patients.

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1365-2133.2001.04014.xDOI Listing

Publication Analysis

Top Keywords

cd4+ cd26-
36
cd26- percentage
24
peripheral blood
20
absolute values
16
cd26-
12
blood involvement
12
percentage values
12
values higher
12
eisd b0-mf
12
patients
10

Similar Publications

An abnormal increase in CD26(-)CD28(-) cytotoxic effector CD4 and CD8 T cell populations in patients with systemic lupus erythematosus.

Int Immunol

October 2024

Department of Therapy Development and Innovation for Immune Disorders and Cancers, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Tokyo 113-8421, Japan.

Article Synopsis
  • CD26 is a T cell costimulatory molecule and its levels are usually increased in autoimmune diseases, but decreased in patients with systemic lupus erythematosus (SLE), indicating a unique aspect of SLE pathology.
  • In this study, researchers analyzed CD26+ and CD26(-) T cell populations from SLE patients, finding an abnormal rise in CD26(-) T cells that display characteristics similar to natural killer T cells.
  • The study suggests that evaluating CD26(-)CD28(-) T cell populations may help in understanding and classifying the complex nature of SLE, particularly since their levels can vary significantly even among inactive patients.
View Article and Find Full Text PDF
Article Synopsis
  • This study looked at how lung injuries happen and heal in mice after they were given a harmful substance called lipopolysaccharide (LPS).
  • It found that the worst lung damage happened three days after the LPS was given, but the lungs were mostly healed by the ninth day.
  • Researchers discovered that a specific protein called Dpp4 could be a helpful target for treating lung injuries, while another protein called Fpr2 wasn’t as helpful.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how asthma affects naïve/memory lymphocyte proportions through CD26 levels, aiming to link asthma phenotype/severity with variations in CD26 among various lymphocyte populations.* -
  • Methods included flow cytometry analysis of blood samples from healthy and asthma patients to measure CD26 levels and characterize CD4CD26 T cell subsets, leading to the identification of four distinct inflammatory profiles.* -
  • Results showed that neutrophilic asthma had lower CD4CD26 cells correlated with inflammation, while eosinophilic asthma had expanded CD26 subsets, particularly in atopic patients, indicating a role in chronic inflammation associated with allergic asthma.*
View Article and Find Full Text PDF

Mesenchymal Stem/Stromal Cells Derived from Dental Tissues Mediate the Immunoregulation of T Cells through the Purinergic Pathway.

Int J Mol Sci

September 2024

Mesenchymal Stem Cell Laboratory, Oncology Research Unit, Oncology Hospital, Centro Médico Nacional SXXI, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico.

Human dental tissue mesenchymal stem cells (DT-MSCs) constitute an attractive alternative to bone marrow-derived mesenchymal stem cells (BM-MSCs) for potential clinical applications because of their accessibility and anti-inflammatory capacity. We previously demonstrated that DT-MSCs from dental pulp (DP-MSCs), periodontal ligaments (PDL-MSCs), and gingival tissue (G-MSCs) show immunosuppressive effects similar to those of BM, but to date, the DT-MSC-mediated immunoregulation of T lymphocytes through the purinergic pathway remains unknown. In the present study, we compared DP-MSCs, PDL-MSCs, and G-MSCs in terms of CD26, CD39, and CD73 expression; their ability to generate adenosine (ADO) from ATP and AMP; and whether the concentrations of ADO that they generate induce an immunomodulatory effect on T lymphocytes.

View Article and Find Full Text PDF

Background: Flow cytometry is not routinely performed in clinical laboratories for the diagnosis of classic Hodgkin lymphoma (CHL).

Methods: Fourteen cases of CHL and 132 cases of the control group were studied by 10-color flow cytometry, with markers including CD3, CD4, CD7, CD8, and CD26, as well as calculated parameters such as the CD4:CD8 ratio, percent CD3CD4CD26 T-cells of CD3CD4 T-cells, percent CD3CD4CD26 T-cells of total events, CD7 coefficient of variation among CD3CD4CD26 T-cells, and CD7 median fluorescence intensity of CD3CD4CD26 T-cells relative to CD3CD8 T-cells.

Results: CHL cases showed a median percent CD3CD4CD26 of CD3CD4 T-cells of 72.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!